Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Operating Expenses | 3,990 | 2,360 | 2,850 | 2,410 | 2,690 |
| Operating Income | -3,990 | -2,360 | -2,850 | -2,410 | -2,690 |
| Other Income | -10 | -20 | 40 | 0 | 0 |
| Pre-tax Income | -4,000 | -2,380 | -2,810 | -2,410 | -2,690 |
| Net Income Continuous | -4,006 | -2,382 | -2,804 | -2,413 | -2,696 |
| Net Income | $-4,006 | $-2,382 | $-2,804 | $-2,413 | $-2,696 |
| EPS Basic Total Ops | -0.07 | -0.04 | -0.05 | -0.05 | -0.05 |
| EPS Basic Continuous Ops | -0.07 | -0.04 | -0.05 | -0.05 | -0.05 |
| EPS Diluted Total Ops | -0.07 | -0.04 | -0.05 | -0.05 | -0.05 |
| EPS Diluted Continuous Ops | -0.07 | -0.04 | -0.05 | -0.05 | -0.05 |
| EBITDA(a) | $-3,820 | $-2,190 | $-2,700 | $-2,240 | $-2,520 |